Sign in
Explore the registryTrack Pf-06838435/ fidanacogene elaparvovec's trials

BENEGENE-2

A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

PF-06838435/ fidanacogene elaparvovecOngoingActive not recruitingPhase 3Open NCT03861273 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…